TrialPloS one2025

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.

Elizabeth S Munroe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.